Promising pathway discovered to treat rare childhood brain disease

Credit: Immunity (2024). DOI: 10.1016/j.immuni.2024.05.017 Aicardi-Goutieres syndrome is a rare disease that can trigger dementia in children. Associate Professor Markus Hofer and colleagues in the U.K. are focusing on treatments in the blood vessels in the brain to combat AGS. A study co-led by Associate Professor Markus Hofer (The University of Sydney) and Professor David Hunt (UK Dementia Research Institute at Edinburgh) reveals fresh insight into the mechanisms underlying a rare disease that can cause childhood dementia. The research, featured on the front cover of the journal Immunity, could lead Read More

Related posts:

  1. Promising new target discovered in pancreatic cancer could boost chemotherapy and reduce spread
  2. New protein drug trial produces promising safety results for rare pulmonary condition
  3. World-first study into precision medicine for high-risk childhood cancer yields promising results
  4. Drug approved as sickle cell disease treatment may help stabilize vision in rare genetic disease
  5. New discovery could help treat a rare and severe form of amyloidosis
  6. Researchers reveal new pathway to improve traumatic brain injury outcomes
  7. New cellular mechanisms in Parkinson’s disease discovered
  8. Researchers identify unknown signaling pathway in the brain responsible for migraine with aura

Leave a Reply

Your email address will not be published. Required fields are marked *